, Tracking Stock Market Picks
Enter Symbol:
Opexa Therapeutics, Inc. (OPXA) [hlAlert]

down 5.00 %

Opexa Therapeutics, Inc. (OPXA) rated Buy with price target $18 by Maxim Group

Posted on: Monday,  Sep 28, 2015  10:25 AM ET by Maxim Group

Maxim Group rated Buy Opexa Therapeutics, Inc. (NASDAQ: OPXA) on 09/28/2015, when the stock price was $0.40. Since
then, Opexa Therapeutics, Inc. has lost 5.00% as of 01/26/2016's recent price of $0.38.
If you would have followed this Maxim Group's recommendation on OPXA, you would have lost 5% of your investment in 120 days.

Opexa Therapeutics, Inc. develops and commercializes cell therapies to treat autoimmune diseases such as MS, rheumatoid arthritis, and diabetes. The Company is focused on autologous cellular therapy applications of its proprietary T-cell and stem cell therapies. The Company's lead product, Tovaxin, a T-cell therapy for multiple sclerosis is in Phase IIb trials. The Company holds the exclusive worldwide license for adult multipotent stem cells derived from mononuclear cells of peripheral blood. The technology allows large quantities of monocyte derived stem cells to be produced efficiently for use in autologous therapy, thus circumventing the threat of rejection. The Company is in preclinical development for type one diabetes.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/28/2015 10:25 AM Buy
0.40 18.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy